| Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin’s lymphoma: outcome after high-dose chemotherapy and auto-SCT S Akhtar, AS Al-Sugair, M Abouzied, Y Alkadhi, M Dingle, M Abdelsalam, ... Bone marrow transplantation 48 (12), 1530-1536, 2013 | 64 | 2013 |
| Pure dysgerminoma of the ovary: a single institutional experience of 65 patients H Al Husaini, H Soudy, AED Darwish, M Ahmed, A Eltigani, ... Medical Oncology 29, 2944-2948, 2012 | 57 | 2012 |
| Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience H Al-Husaini, H Soudy, A Darwish, M Ahmed, A Eltigani, W Edesa, ... Clinical and Translational Oncology 17, 409-415, 2015 | 27 | 2015 |
| Pre-transplant 18F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT S Akhtar, AS Al-Sugair, M Abouzied, Y Alkadhi, M Dingle, M Abdelsalam, ... Bone marrow transplantation 48 (4), 551-556, 2013 | 13 | 2013 |
| Whole body 18F-FDG PET predicts progression free and overall survival in squamous cell carcinoma of the esophagus: results of a prospective trial M Abdelsalam, S Bazarbashi, M Abouzied, T Amin, H Soudy, M Rahal, ... Hematology/Oncology and Stem Cell Therapy 3 (4), 179-184, 2010 | 10 | 2010 |
| Evaluation of adjuvant therapy in women with uterine papillary serous cancer H Al Husaini, H Soudy, A Darwish, M Ahmed, A Eltigani, W Edesa, ... Annals of Saudi Medicine 32 (1), 27-31, 2012 | 3 | 2012 |
| Predictive value of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) prior to high dose chemotherapy and autologous stem cell transplant in patients with Hodgkin … M eldin Abouzied, A Al-Sugair, Y Al Kadhi, M Dingle, M Abdelsalam, ... Journal of Nuclear Medicine 51 (supplement 2), 349-349, 2010 | 2 | 2010 |
| Prognostic clinicopathological parameters in colorectal carcinoma B Ibrahim, M Allhayni, R Alharbi, L Alghamdi, M Beragdar, A Darwish International Journal of Medicine in Developing Countries 8 (8), 1856-1856, 2024 | | 2024 |
| Early stage diffuse large B-cell lymphoma treated with CHOP with or without rituximab (R): Outcome analysis according to risk stratification I Maghfoor, H Soudy, A Darwish, T Elhassan, MA Salam, A Rehman, ... EUROPEAN JOURNAL OF CANCER 49, S847-S847, 2013 | | 2013 |
| International Prognostic Index (IPI) is a stronger predictor of outcome in diffuse large B cell lymphoma (DLBCL) treated with rituximab (R) and CHOP (R-CHOP) compared to … H Soudy, N Bakshi, A Darwish, MA Salam, A Rehman, T Elhassan, ... EUROPEAN JOURNAL OF CANCER 49, S846-S846, 2013 | | 2013 |
| Prognostic significance of international prognostic index (IPI) individual risk factors in patients with diffuse large b cell lymphoma (DLBCL) treated with rituximab (R) and … S Akhtar, H Soudy, A Darwish, MA Salam, T Elhassan, A Rehman, ... EUROPEAN JOURNAL OF CANCER 49, S847-S847, 2013 | | 2013 |
| High dose chemotherapy and autologous stem cell transplantation for chemo-sensitive primary refractory diffuse large B-cell lymphoma: prognostic factor and survival analysis of … S Akhtar, T Elhassan, A Darwish, H Soudy, M Nabil-Ahmed, I Maghfoor BONE MARROW TRANSPLANTATION 48, S424-S425, 2013 | | 2013 |
| Rituximab plus salvage chemotherapy (ESHAP) has superior overall and event free survival after HDC ASCT compared to non-rituximab salvage in relapsed and primary refractory … S Akhtar, H Soudy, T Elhassan, A Darwish, M Nabil-Ahmed, I Maghfoor BONE MARROW TRANSPLANTATION 48, S424-S424, 2013 | | 2013 |
| Pre-transplant FDG-PET scan response and other prognostic factors based survival model in patients with relapsed and refractory Hodgkin's lymphoma is useful to predict outcome … S Akhtar, A Al-Sugair, M Abouzied, Y AlKadhi, M Abdelsalam, M Dingle, ... BONE MARROW TRANSPLANTATION 48, S49-S50, 2013 | | 2013 |
| Combination chemotherapy with capecitabine (C), irinotecan (I), oxaliplatin (O), and bevacizumab (B; XELOXIRIA) as first-line treatment of metastatic colorectal cancer (MCRC … S Bazarbashi, AH Aljubran, H Soudy, A Darwish, A Eltigani, ... Journal of Clinical Oncology 29 (15_suppl), e14073-e14073, 2011 | | 2011 |
| A NEW PRE-TRANSPLANT PREDICTIVE MODEL FOR EVENT FREE SURVIVAL INCORPORATING FUNCTIONAL IMAGING USING FDG-PET IN LYMPHOMA PATIENTS UNDERGOING HDC & ASCT S Akhtar, A Al-Sugair, M Abuzaid, Y Al Kadhi, M Dingle, M Abdelsalam, ... HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95, 208-209, 2010 | | 2010 |
| 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG PET) RESPONSE PREDICTS SURVIVAL IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA M Abdelsalam, A El Weshi, M Abouzied, H Al Husseini, H Soudy, ... HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95, 115-115, 2010 | | 2010 |
| 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) prior to high-dose chemotherapy and autologous stem cell transplant predicts outcome after ASCT in patients with … S Akhtar, A Al-Sugair, M Abuzaid, Y Al Kadhi, M Dingle, M Abdelsalam, ... BONE MARROW TRANSPLANTATION 45, S247-S247, 2010 | | 2010 |
| WHOLE BODY 18 FDG-PET PREDICTS PROGRESSION FREE AND OVERALL SURVIVAL IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: A PROSPECTIVE TRIAL M Abdelsalam, S Bazarbashi, T Amin, H Soudy, M Memon, M Rahal, ... ANNALS OF ONCOLOGY 19, 171-171, 2008 | | 2008 |
